骨血管肉瘤和许多肝转移呈现卡萨巴赫-梅里特现象
Toshiro Masuda1, Toru Beppu2, Yasunori Nagayama3
1Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Anticancer research
|March 28, 2025
概括
转移性脏血管肉瘤与卡萨巴赫-梅里特现象需要准确的诊断和治疗. 化疗,如帕克利塔克塞尔和帕佐帕尼布,可以控制这种罕见的癌症及其相关的凝血病.
科学领域:
- 在瘤学瘤学.
- 血管瘤 血管瘤
- 血液学 血液学 血液学
背景情况:
- 脏血管肉瘤是一种罕见且具有攻击性的恶性瘤.
- 转移的脏血管肉瘤可以与Kasabach-Merritt现象一起出现,这是一个严重的凝血病.
研究的目的:
- 研究转移性脏血管肉瘤的诊断方法和治疗策略.
- 在这种背景下,评估卡萨巴赫-梅里特现象的管理.
主要方法:
- 一个76岁的男性患有脏血管肉瘤和卡萨巴赫-梅里特现象的病例报告.
- 诊断成像包括对比度增强的CT和MRI.
- 治疗包括抗凝固剂-纤维素解药疗法,治疗缺血的手术干预和化疗 (帕克利塔克塞尔,帕佐帕尼布).
主要成果:
- 通过肝脏瘤的免疫组织化学分析证实了诊断.
- 患者经历了需要手术切除和结节切除的结节缺血症.
- 用帕克利塔克塞尔和帕佐帕尼布进行的化疗导致疾病稳定,并控制了卡萨巴赫-梅里特现象.
结论:
- 准确的诊断,手术干预和化疗对于管理Kasabach-Merritt现象的转移性脏血管肉瘤至关重要.
- 卡萨巴赫-梅里特现象作为化疗反应的指标.
- 对新型化疗的进一步研究是有必要的.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...


